|
Synonyms: GSK3882347
Compound class:
Synthetic organic
Comment: Luxafimloc (also known as GSK3882347) is an orally bioavailable, mannose-containing small molecule with promising anti-virulence activity against uropathogenic Gram-negative bacteria. The chemical structure is claimed in GSK patent WO2020012336A1 [1] and was presented during the ACS Fall 2026 meeting's First Time Disclosures session [2].
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| According to data presented at the ACS Fall 2026 meeting [2], luxafimloc displays low nanomolar potency in inhibiting bacterial binding in a whole cell-based assay. The drug also demonstrates excellent oral bioavailability in rodents and effectively prevents and treats bladder infections in mouse models of uncomplicated urinary tract infections (uUTIs). |